Effects of a novel spermine oxidase inhibitor SI-4650 on proliferation and EMT of human ovarian cancer SKVO-3 cells

doi:10.12047/j.cjap.6249.2022.027

Abstract

Abstract: Objective: To investigate the effects of SI-4650, a novel small molecule inhibitor of spermine oxidase (SMO), on the proliferation and epithelial mesenchymal transformation (EMT) of human ovarian cancer SKVO-3 cells as well as its underlying molecular mechanisms. Methods: SKVO-3 cells treated with 0 μmol/L SI-4650 were used as control group, SKVO-3 cells treated with 30, 60 μmol/L SI-4650 were used as experimental group. The effects of SI-4650 on the activity of SMO, the polyamine contents and the cellular reactive oxygen species (ROS) were detected. Cell proliferation, cell cycle and mitochondrial membrane potential change of SKVO-3 cells were tested. The effects of SI-4650 on apoptosis, migration and invasion were investigated. The effects of SI-4650 on Bax, Bcl-2, Caspase3, E-cadherin, N-cadherin, Vimentin, matrix metalloproteinase 2 ( MMP2) and MMP 9 expression levels in SKVO-3 cells were detected. Results: Comparison between blank control group and experimental groups,SI-4650 could improve the content of SI-4650 in SKVO-3 cells. SI-4650 could inhibit the activity of SMO (P＜0.01), reduce the ROS (P＜0.01)and polyamine content in SKVO-3 cells (P＜0.01). Treatment of SKVO-3 cells with SI-4650 inhibited the proliferation (the inhibition rate was 32.27% and 47.31% in experimental groups), caused S-phase cell cycle arrest (P＜0.01) and induced apoptosis (P＜0.01). The expressions of Bax and c-Caspase3 in SKVO-3 cells were increased (P＜0.01),the content of Bcl-2 was decreased (P＜0.01), and the mitochondrial membrane potential was decreased (P＜0.01), and the number of apoptotic cells was increased(31.41% and 43.51% in experimental groups). At the same time, SI-4650 could change the expression levels of EMT-related factors, increased the expression level of E-cad , decreased the expression levels of N-cad, Vimentin, MMP-2 and MMP-9, and inhibited the migration and invasion of SKVO-3 cells. Conclusion: SI-4650 can effectively inhibit proliferation, invasion and metastasis of human ovarian cancer SKVO-3 cells, and the mechanism may be related to its ability to depress the activity of SMO, interfere polyamine metabolism and induce cell cycle arrest, mitochondrial apoptosis and inhibit EMT. This study reveals potential application of SI-4650 in the treatment of ovarian cancer.

Key words: inhibitor of spermine oxidase, human ovarian cancer cell, cell culture, cell proliferation, apoptosis, migration and invasion

CLC Number:

R966

YANG Jian- lin, TIAN Jia-jun, ZHANG Hao, CHEN Qiao-ying, LYU Ya-feng, CAO Chun-yu. Effects of a novel spermine oxidase inhibitor SI-4650 on proliferation and EMT of human ovarian cancer SKVO-3 cells[J]. CJAP, 2022, 38(2): 175-180.

References

[1] Nakanishi S, Cleveland JL. Polyamine homeostasis in development and disease[J].Med Sci(Basel), 2021, 9(2): 28-45.
[2] Casero RA Jr, Murray Stewart T, Pegg AE. Polyamine metabolism and cancer: treatments, challenges and opportunities[J]. Nat Rev Cance, 2018, 18(11): 681-695.
[3] McNamara KM, Gobert AP, Wilson KT. The role of polyamines in gastric cancer[J].Oncogene, 2021, 40(26): 4399-4412.
[4] Peng Q, Wong CY, Cheuk IW, et al. The Emerging clinical role of spermine in prostate cancer[J]. Int J Mol Sci, 2021, 22(9): 4382-4401.
[5] Gerner EW, Bruckheimer E, Cohen A. Cancer pharmacoprevention: Targeting polyamine metabolism to manage risk factors for colon cancer[J].Biol. Chem, 2018, 293(48): 18770-18778.
[6] Dunston TT, Khomutov MA ,Gabelli SB, et al. Identification of a novel substrate-derived spermine oxidase inhibitor[J]. Acta Naturae, 2020, 12(3): 140-144.
[7] Sun L, Yang J, Qin Y, et al . Discovery and antitumor evaluation of novel inhibitors of spermine oxidase[J]. J enzym inhib med ch, 2019, 34(1): 1140-1151.
[8] Goodwin AC, Murray-Stewart TR, Casero RA Jr. A simple assay for mammalian spermine oxidase: a polyamine catabolic enzyme implicated in drug response and disease [J].Methods Mol Biol, 2011, 720: 173-181.
[9] Song Z, Zhou Y, Bai X, et al. Apractical nomogram to predict early death in advanced epithelial ovarian Cancer[J]. Front Oncol, 2021,(11): 655826-655837.
[10] Sagar NA, Tarafdar S, Agarwal S, et al . Polyamines: Functions, metabolism, and role in human disease management[J]. Med Sci(Basel), 2021, 9(2): 44-47.
[11] Cervelli M, Salvi D, Polticelli F, et al. Structure-function relationships in the evolutionary framework of spermine oxidase [J]. Mol Evol, 2013, 76(6): 365-370
[12] Sierra JC, Piazuelo MB, Luis PB, et al. Spermine oxidase mediates helicobacter pylori-induced gastric inflammation, DNA damage, and carcinogenic signaling[J]. Oncogene, 2020, 39(22): 4465-4474.
[13] SHuang Z, Wang S, Zhang H J, et al. MOX expression predicts the prognosis of non-small cell lung cancer[J]. Ann Transl Med, 2021, 9(13): 1048-1048.
[14] 樊小群, 李欢, 朱华雄, 等. Mir-335-5p靶向G6PD对结肠癌细胞增殖、凋亡的影响[J]. 中国应用生理学杂志, 2021, 37(4): 402-406.
[15] Zhou Y, Wang YL, Ccao CY, et al. Molecular mechanism underlying the inhibitory effect of spermine oxidase inhibitor SI-4650 on proliferation of a human malignant melanoma cell line A375[J]. Chin J Dermatol, 2019, 10(52): 722-728.
[16] 黄娇娇, 王艳林, 孙丽丹, 等. 新型多胺代谢酶抑制剂SI-4650对结肠癌CT-26细胞增殖的影响及其机制[J]. 中国应用生理学杂志, 2020, 36(4): 330-335.
[17] 谭建军, 隆姝孜, 张涛. LncRNA UNC5B-AS1对肺癌细胞黏附、侵袭及迁移的影响及其机制[J]. 中国应用生理学杂志, 2020, 36(6): 622-627.
[18] Dai F, Yu W, Song J, et al. Extracellular polyamines-induced proliferation and migration of cancer cells by ODC, SSAT, and Akt1-mediated pathway[J]. Anticancer Drugs, 2017, 28(4): 457-464.